In Alzheimer's disease neuritic amyloid-β plaques together with surrounding activated microglia and astrocytes are thought to play an important role in the inflammatory events leading to neurodegeneration. Studies have indicated that amyloid-β can be direct neurotoxic and, by activating these glial cells to produce oxygen radicals and pro-inflammatory cytokines. This report shows that, using primary human monocyte-derived macrophages as model cells for microglia, amyloid-β(1-42) stimulate these macrophages to the production of superoxide anions and TNF-α. In contrast, astrocytes do not produce both inflammatory mediators when stimulated with amyloid-β(1-42). In cocultures with astrocytes and amyloid-β(1-42)-stimulated macrophages decreased levels of both superoxide anion and TNF-α were detected. These decreased levels of potential neurotoxins were due to binding of amyloid-β(1-42) to astrocytes since FACSscan analysis demonstrated binding of FITC-labeled amyloid-β(1-42) to astrocytoma cells and pretreatment of astrocytes with amyloid-β(1-16) prevented the decrease of superoxide anion in cocultures of human astrocytes and amyloid-β(1-42)-stimulated macrophages. In order to elucidate an intracellular pathway involved in TNF-α secretion, the activation state of NF-κB was investigated in macrophages and astrocytoma cells after amyloid-β(1-42) treatment. Interestingly, while activation of NF-κB could not be detected in amyloid-β-stimulated macrophages it was readily detected in astrocytoma cells. These results not only demonstrate that amyloid-β stimulation of astrocytes and macrophages result in different intracellular pathway activation but also indicate that astrocytes attenuate the immune response of macrophages to amyloid-β(1-42) by interfering with amyloid-β(1-42) binding to macrophages.
Introduction
Alzheimer's disease (AD) is the most common cause of progressive dementia and a neurodegenerative disorder, which despite scientific progress in recent years is still a disease of unknown etiology. One pathological hallmark of AD is the presence of neuritic plaques in the cortical gray matter (1) . These extracellular depositions are mainly composed of aggregated amyloid-β (Aβ) peptides and are surrounded by dystrophic neurites and glial cells. The Aβ peptide is derived through changes in the processing of the amyloid-β precursor protein (APP) and according to the 'amyloid cascade hypothesis' these changes are central to the disease process (2) . Aβ is a 4 kDa peptide of 39-43 amino acids (3, 4) and studies with synthetic Aβ show that it can act as a potent and direct neurotoxic agent (5-7).
There is however an increasing amount of evidence that Aβ can be indirect neurotoxic by activating surrounding glial cells. Neuritic plaques, but not diffuse plaques, are reported to be surrounded by microglia (8) (9) (10) (11) . Since microglia are able to produce cytokines as well as chemotactic and neurotoxic factors a lot of research has focused on the ability of Aβ to induce these events in microglia. Recent studies show that Aβ is able to trigger the generation of reactive oxygen species (ROS) in rat microglia and THP-1 monocytes (12) (13) (14) . Excessive release of ROS not only leads to oxidative stress but may also potentiate the inflammatory response, e.g. by triggering redox-sensitive expression of various inflammatory genes (5, 15, 16) . Aβ has also been shown to induce interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), transforming growth factor-β (TGF-β) and neurotrophic molecules like nerve growth factor (NGF) and basic fibroblast growth factor (bFGF) in THP-1 monocytes (17) (18) (19) .
Aβ, cytokines and ROS released by microglia cannot only be direct neurotoxic, they may also activate surrounding astrocytes. Astrocytes are associated with many, but not all senile plaques. They are most closely associated with plaques with a dense amyloid core and an attendant microglial reaction (20) (21) (22) . In vitro studies show that Aβ can stimulate the production of IL-1β and NO in rat astrocytes (23, 24) . It has also been shown that activity of iNOS in microglial cells is inhibited by the presence of astroglial cells, probably involving TGF-β (25) . In addition, astrocytes have been shown to inhibit phagocytic properties of microglial cells (26) .
Although extensive research has shown that microglia as well as astrocytes are involved in the inflammatory process occurring around neuritic plaques it remains unclear how Aβ activates these microglia and astrocytes. Research of the microglial signal transduction pathways mediating the neurotoxic response of Aβ has revealed the mitogenactivated protein kinase (MAPK) superfamily members ERK1/2 and p38 MAPK as important mediators (27, 28) . Besides, an increasing amount of evidence shows that the transcription factor nuclear factor-κB (NF-κB) can be stimulated by Aβ in neurons (5, 16, 29) and by Aβ (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) in microglia (30, 31) . Upregulation of ERK1/2 and p38 MAPK can lead to the activation of numerous transcription factors in their turn leading to the activation of cytokines and neurotrophic factors. Activation of NF-κB can lead to the transcription of genes expressing TNF-α, IL-1, IL-6, monocyte chemoattractant protein-1 (MCP-1) and nitric oxide (NO) synthase (reviewed in (15) ).
To further explore the microglia and astrocyte-mediated inflammatory pathways, in the present study the capability of Aβ to induce NF-κB, TNF-α and superoxide anions in microglia and astrocytes was investigated. In addition the production of these proinflammatory molecules was also investigated in cocultures of these cells in order to reveal the intercellular relationship regarding Aβ-induced central nervous system (CNS) inflammation.
Materials and Methods

Cells
Monocytes were derived from peripheral blood mononuclear cells by Ficoll-Paque (Pharmacia Biotech, Sweden) density gradients and purified by centrifugal elutriation as described previously (32) . Cells were seeded at a concentration of 2 x 10 6 cells / ml in Teflon Erlenmeyer flasks (Nalgene, USA) and grown as suspension at 37 °C in a humidified atmosphere of 5% CO 2 / 95% air. Culture medium was composed of Iscove's modified Dulbecco's medium (Gibco Life Technologies, The Netherlands) supplemented with 10% (v/v) heat-inactivated human AB serum, 2 mM L-glutamine, 19 mM sodium bicarbonate, 10 µg/ml gentamicin and 0.5 µg/ml ciprofloxacin. After 7 days, monocytederived macrophages (MDMs) were harvested from the flasks, washed with Hanks' balanced salt solution (HBSS) and used for the experiments. The human astrocytoma cell line U-373 MG was grown in a humidified atmosphere of 5% CO 2 / 95% air in Dulbecco's modified eagle medium / Nutrient mixture Ham F-10 (Gibco Life Technologies), 1:1, supplemented with 10% (v/v) fetal calf serum, 10 IU / ml penicillin, 10 IU / ml streptomycin and 1.2 mM L-glutamine.
Primary human adult astrocytes were kindly provided by Dr. C.J.A. de Groot and were cultured as described earlier (33) . In short, cells were seeded into poly-L-lysine (PLL; 15 µg/ml; Sigma Chemical Co., The Netherlands) coated 80 cm 2 flasks at a density of 2 x 10 4 cells/ml in Dulbecco's modified eagle medium / Nutrient mixture Ham F-10, 1:1, supplemented with 10% (v/v) fetal calf serum, 10 IU / ml penicillin, 10 IU / ml streptomycin. For each new passage confluent cultures of astrocytes were harvested using 0.25% trypsin in 0.02% EDTA.
Amyloid-β peptides
The synthetic Aβ peptides Aβ and Aβ(1-16) (Bachem AG, Switzerland), prepared as stock solutions in sterile water at a concentration of 500 µM, were stored at -20 ºC. FITC-labeled Aβ(1-42) was prepared by incubating Aβ(1-42) at a concentration of 10 mg/ml with 0.1 mg/ml FITC in PBS (pH = 7.4) for 1 h at 22 ºC. Subsequently, using a 1 kDa Spectra/Pordialyzation membrane, Aβ(1-42)-FITC was dialyzed overnight against PBS to remove unbound FITC, diluted to a concentration of 220 mM and stored at -20 ºC.
Preparation of nuclear extracts
MDMs or astrocytoma cells (1 x 10 6 cells / sample) were incubated with 10 µM Aβ(1-42) for 1 h at room temperature. Hereafter nuclear extracts were prepared as described previously (34) . Briefly, cells were pelleted, washed with TRIS-buffered saline and resuspended in an ice-cold hypotonic buffer. Cells were allowed to swell on ice for 15 min, after which a solution of Nonidet NP-40 was added. After centrifugation the pellet was vigorously shacked in an ice-cold hypertonic buffer. Nuclear extracts were centrifuged and the supernatant was aliquoted and stored at -70 °C until use.
P50 and p65 positive controls were obtained as described before (35) . In short, COS-1 cells were grown in 10 cm dishes and transfected with 20 µg of expression plasmid by the calcium-phosphate precipitation method. Cells were harvested 48 h post-transfection after which whole cells extracts were made. Extracts were stored at -70 °C until use.
Electrophoretic mobility shift assay (EMSA)
Nuclear extracts (5 µg protein per sample) were incubated with a double stranded 32 P-labeled probe containing the NF-κB binding motif from the HIV-long terminal repeat (HIV-LTR, 5'-agcttcagaGGGGACTTTCCgagagg-3'). Incubation was carried out at room temperature for 30 min in 20 µl (total volume) of 10 mM Tris-HCl (pH 7.5), 1 mM EDTA, 5% glycerol, 1 mM DTT, 2 µg poly(dI-dC), 1 µg BSA, 100 mM NaCl and 1 ng probe. Hereafter, samples were loaded on a 5% polyacrylamide gel and run until free probe was at the end of the gel. Films were exposed to vacuum dried gels at -70 °C in cassettes containing intensifying screens.
TNF-α ELISA
Macrophages were grown in teflon flasks for six days after which they were seeded in a 48-well plate (4 x 10 5 / well). For coculture experiments astrocytes were grown in 24-well plates. When confluent an equal amount of macrophages was added. Cells then were incubated with 10 µM Aβ(1-42) for indicated times at 37 °C in a humidified atmosphere of 5% CO 2 / 95% air. TNF-α concentration in the supernatant was quantified with an enzymelinked immunosorbent assay (ELISA). In short, TNF-α was captured by monoclonal antihuman TNF-α antibody and detected with a biotinylated anti-human TNF-α antibody according to the manufacturer's instructions (Pelikine compact human TNF-a ELISA kit, Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam, The Netherlands)
Superoxide anion production
Superoxide production was measured as lucigenin-enhanced chemiluminescence (36) . Briefly, cells were transferred to polystyrene vials (2 x 10 5 / vial), placed into a luminometer (Packard Instruments, Belgium) and incubated for 30 min at 37 °C in HBSS containing 250 nM bis-N-methylacridinum (Lucigenin; Sigma Chemical Co., The Netherlands) to assess the spontaneous release of superoxide. Subsequently, Aβ peptides were added and chemoluminescence (expressed as millivolts, mV) was monitored for 30 min. 
Statistical analysis
The non-parametric Wilcoxon signed-rank test for two related samples was used to compare TNF-α secretion in unstimulated and Aβ(1-42)-stimulated macrophages (Fig 1) . The Wilcoxon test was also used to compare TNF-α secretion in Aβ(1-42)-stimulated macrophages and Aβ(1-42)-stimulated macrophages cocultured with astrocytoma cells (Fig  2A) and primary human adult astrocytes (Fig 2B) . Reported p-values are two-sided. All statistical analyses were performed using SPSS for Windows (8.0.0). 
Results
TNF-α secretion by Aβ(1-42)-stimulated primary human macrophages is attenuated by astrocytes
To investigate whether Aβ(1-42) is capable of inducing primary human macrophages to produce pro-inflammatory cytokines and thus being indirectly neurotoxic MDMs were stimulated with 10 µM Aβ(1-42) for 4, 8, 16 and 24 hours and TNF-α concentrations were measured in the supernatant. As indicated in Figure 1 there is a significant (p=0.018) increase in TNF-α secretion at 4, 8, 16 and 24 hours as compared to unstimulated control cells. Maximum TNF-α secretion was measured after 24 hours of incubation. Our results are supported by reports published earlier by Fiala et al. (37) and Klegeris et al. (19) where TNF-α secretion was measured in human monocytes and human monocytic THP-1 cells respectively. Figure 2A shows TNF-α levels of human macrophages and human astrocytoma cells incubated with 10 µM Aβ(1-42) for 6 hours, Figure 2B shows TNF-α levels of human macrophages and primary human adult astrocytes incubated with 10 µM Aβ(1-42) for 6 hours. Whereas macrophages can produce significant levels of TNF-α, astrocytoma cells and primary human adult astrocytes do not when stimulated with Aβ(1-42). When stimulated macrophages are cocultured with either unstimulated astrocytoma cells or unstimulated primary human adult astrocytes there is a significant decrease in TNF-α secretion by these macrophages compared to Aβ(1-42)-stimulated macrophages (p=0.028 and p=0.032 respectively).
Theoretically, several mechanisms may account for the observed decrease in TNF-α levels in the macrophage-astrocyte cocultures. Among them are the ability of astrocytes to bind Aβ(1-42) and in such a way interfere with Aβ(1-42) activation of macrophages, the ability to bind TNF-α and in such way decrease the levels of TNF-α in the supernatant, the ability to produce macrophage deactivating molecules such as IL-10 and TGF-β or other molecules such as soluble TNF-α receptor. To study the binding of Aβ to human astrocytes, astrocytoma cells were incubated with different concentrations of FITC-labeled Aβ . Figure 3 shows that increasing concentrations of FITC-labeled Aβ(1-42) results in an increase in fluorescence intensity of the cells. Moreover, preincubating astrocytoma cells with 50 µM unlabeled Aβ(1-16) for 30 min before incubation with 10 µM Aβ(1-42)-FITC shows a decrease in fluorescence intensity of the cells (Fig 3E) . These data suggest that astrocyte binding of Aβ(1-42) interferes with Aβ(1-42) activation of macrophages.
Superoxide anion production of Aβ(1-42)-stimulated primary human macrophages is attenuated by astrocytes
In order to study the effect of Aβ(1-42) on superoxide anion production by human macrophages, astrocytoma cells, primary human adult astrocytes and combined macrophage-astrocytoma and macrophage-primary human adult astrocyte cultures were placed into a luminometer and stimulated with Aβ . Figure 4A shows that macrophages do produce superoxide anions, Figure 4B shows that astrocytoma cells do not when stimulated with 10 µM Aβ(1-42) . Figure 4E shows that primary human adult astrocytes also do not produce superoxide anions when stimulated with 10 µM Aβ(1-42) . There was however a decrease in the respiratory burst of macrophages when cocultured with astrocytoma cells (Fig 4C) or human adult astrocytes (Fig 4F) . To investigate this effect astrocytoma cells and human adult astrocytes were pre-incubated with 50 µM Aβ(1-16) for 15 min, prior to the Aβ(1-42) incubation, thereby blocking the binding of Aβ to these astrocytes (38) . The results, shown in Figure 4C and 4F, show that the attenuation of the respiratory burst by astrocytoma cells and human adult astrocytes was neutralized concluding that binding of Aβ to the astrocytes might interfere with Aβ(1-42) activation of macrophages which in turn might result in a decreased superoxide anion production. Primary human adult astrocytes incubated with 50 µM Aβ(1-16) alone did not show any superoxide anion production (data not shown) or TNF-α production (Fig 2B) . which they were coincubated with macrophages and exposed to buffer or Aβ . Also macrophages alone were exposed to 10 µM Aβ(1-42). Experiment was repeated using primary human adult astrocytes. (D) Macrophages are exposed to buffer or 10 µM Aβ(1-42), (E) primary human adult astrocytes are exposed to buffer or 10 µM
Aβ(1-42). (F)
To investigate the effect of astrocytes on the respiratory burst of macrophages, human astrocytes were preincubated for 15 min with buffer or 50 µM Aβ(1-16) after which they were coincubated with macrophages and exposed Aβ . Also macrophages alone were exposed to 10 µM Aβ . Results are representative of five independent experiments each using macrophages from different donors. 
Aβ(1-42)-induced NF-κB activity in human astrocytoma cells, human macrophages and cocultures their of
To investigate the role of astrocytes in the inflammatory process occurring around neuritic plaques the activation state of NF-κB in Aβ(1-42)-stimulated human U-373 MG astrocytoma cells was characterized. Therefore cells were stimulated with 10 µM Aβ(1-42) for 3, 6, 12 and 24 hours (3, 12 and 24 hour data not shown). Maximal NF-κB stimulation was seen after 6 hours (Fig 5). Aβ(1-42) stimulation results in the appearance of band A (Fig 5: lane 4) when compared to unstimulated control cells (Fig 5: lane 3) . To identify band A we performed a supershift by incubating nuclear extracts and 32 P-labeled oligonucleotide probes together with an antibody against either the p50 or the p65 subunits of NF-κB (Fig 5: lanes 5 and 6 respectively) . The appearance of bands S1 and S2 indicate that stimulation of astrocytes with Aβ(1-42) results in activation of the NF-κB heterodimer p50/p65. To confirm these results the same experiment was performed with a new batch of astrocytoma cells. Cells were stimulated with 10 µM Aβ(1-42) for 3, 6, 12 and 24 hours. Maximal NF-κB stimulation was seen after 6 hours (Fig 6) . Aβ(1-42) stimulation resulted in the appearance of band A (Fig 6: lane 3) compared to unstimulated astrocytoma cells (Fig 6: lane 2) . Nuclear extracts of Aβ(1-42)-stimulated astrocytoma cells incubated with a 50 fold excess of cold NF-κB probe showed a disappearance of band A (Fig 6: lane 4) .
As shown in Figure 2B cocultures of primary human adult astrocytes and macrophages produced decreased TNF-α levels as compared to macrophages alone. Although the mechanism behind the decreased levels of TNF-α is related to Aβ(1-42)-astrocyte binding, the astrocytes may also bind at least part of the TNF-α produced by macrophages. To investigate whether TNF-α can bind to astrocytes and stimulate NF-κB activation, human U-373 MG astrocytes were incubated for 6 hours with either 10 µM Aβ(1-42) (Fig 7: lane 2 We showed that Aβ(1-42) could induce superoxide anion production as well as TNF-α secretion in human macrophages. To investigate whether NF-κB can be activated by Aβ in human macrophages we incubated MDMs with 10 µM Aβ(1-42) for 3,6,12 and 24 hours. Figure 8 shows the 3 hour incubation of macrophages with Aβ . Aβ(1-42) stimulation (lane 2) does not increase NF-κB activity as compared to unstimulated control cells (lane 1). 6, 12 and 24 hour incubation periods show the same results (data not shown).
As shown in Figure 2B and 4B, cocultures of human astrocytes and Aβ(1-42)-stimulated macrophages produced decreased TNF-α levels as well as superoxide anion levels compared to macrophages alone. Therefore, NF-κB activity in cocultures of Aβ(1-42)-stimulated macrophages and astrocytoma cells was determined (data not shown). Results show no difference of NF-κB activity in cocultures compared to macrophages alone (data not shown). 
Discussion
In recent years, it has become increasingly evident that both Aβ and microglial cells play a fundamental role in the pathogenesis of AD. Aβ is not only believed to be direct neurotoxic, by activating microglial cells Aβ might be indirect neurotoxic. Although various receptors are reported to bind Aβ as a ligand (39-41), a specific receptor for Aβ on macrophages has not been found yet. However, it is suggested that the 1-16 domain of the peptide is believed to be responsible for binding to the macrophage, thereby activating numerous intracellular signal transduction pathways leading to transcription and production of pro-inflammatory products (38, 42, 43) . Induction of TNF-α has been shown in THP-1 monocytic cells and in rat and murine microglial cells (19, (44) (45) (46) . The induction of monocytic activation has been achieved by many investigators using micromolar concentration of Aβ (28, 37, 45, (47) (48) (49) (50) . Indeed, stimulation of THP-1 cells with nanomolar concentration did not result in monocytic activation as measured by the release of proinflammatory products (51) . This report shows that using primary human monocyte-derived macrophages as a model cell for microglia, activation of these macrophages by Aβ(1-42) not only resulted in the production of superoxide anions but also preceded the release of TNF-α. Although TNF-α is reported to be neuroprotective under certain conditions (52) , the ability of Aβ to induce the release of TNF-α and superoxide anions in macrophages and the capability of TNF-α and reactive oxygen species to amplify the inflammatory reaction by numerous mechanisms in surrounding microglia and astrocytes underscores the importance of understanding the underlying molecular mechanisms in an attempt to slow or prevent injury to the brain. Proposed mechanism of intercellular pathways eventually leading to neuronal degeneration. Aβ can activate macrophages (1) to produce either TNF-α (2) or superoxide anions (3). TNF-α (4) and superoxide anions (5) can activate astrocytes or can be direct neurotoxic (6 + 7). Aβ may also activate proinflammatory transcription factors (NF-κB) in astrocytes (8) . Activation of astrocytes by either TNF-α, superoxide anions or Aβ may lead to the production of proinflammatory neurotoxic products (9) . +: able to induce, -: not able to induce, †: neurotoxic.
There have been several studies investigating the intracellular pathways stimulated as a result of Aβ activation of the macrophage. The NF-κB family of proteins is a wellcharacterized transcription factor, which has gained considerable attention because of its unique mechanism of activation, its role in cytoplasmic/nuclear signaling and its exquisite responsiveness to pathogenic stimulation of cells. Several studies reported a relationship between Aβ and NF-κB activity in neurons (5, 16, 29, 53) and astrocytes (24) . In microglia Bonaiuto et al. showed NF-κB activation upon Aβ-stimulation (29, 30) . In this study however, a N9 murine microglial cell line was used. This report shows that Aβ was not able to induce NF-κB in primary human macrophages, in contrast to LPS (data not shown). However, incubating human astrocytes with Aβ(1-42) not only shows binding of the peptide to the cells but also shows activation of NF-κB, more specific the heterodimer p50/p65. Because NF-κB is known to be able to stimulate the transcription of TNF-α it can be concluded that because macrophages but not astrocytes showed TNF-α secretion after stimulation with Aβ(1-42) the intracellular pathway following this Aβ(1-42) stimulation in macrophages is different than in astrocytes. Other studies however showed an increased TNF-α secretion upon induction with Aβ (54, 55) . In these studies rat astrocytes were used, in contrast to the primary human adult astrocytes used in this study. This contradiction indicates that there are species differences regarding Aβ-stimulated TNF-α production. Although the expression of TNF-α is under control of NF-κB additional cellular transcription factors are necessary for the induction of TNF-α expression (56) . Indeed, in addition to the results presented in this paper, NF-κB activity is reported to be constitutively present in monocytes (57) and MDMs (58, 59) . In astrocytes other, inhibitory factors, seem responsible for not producing TNF-α as a consequence of Aβ-stimulated NF-κB activity. Astrocytes do however produce TNF-α when stimulated with LPS and this production is strongly amplified in the presence of Aβ (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) while Aβ(25-35) alone does not show this effect (60) .
Besides Aβ(1-42)-mediated NF-κB activation, this report also showed that TNF-α could induce NF-κB. Moreover TNF-α in combination with Aβ(1-42) showed an even higher NF-κB activity. Because astrocytes do not produce proinflammatory TNF-α and superoxide anions when stimulated with Aβ, other mechanisms might follow the activation of NF-κB. Akama et al. showed that in astrocytes Aβ stimulation of nitric oxide production occurs through an NF-κB dependent mechanism (24) . Another study showed that IL-1β and TNF-α-stimulated alpha 1-antichymotrypsin production in astrocytes occurs via NF-κB (61) . Astrocytes are also reported to produce IL-6 and IL-8 after stimulation with Aβ (62). In addition, our results show a neuroprotective role for astrocytes regarding the amount of superoxide anion and TNF-α release by macrophages induced in the presence of Aβ (Fig  9) . Taken together, these results not only demonstrate that upon binding and activation of Aβ to astrocytes and macrophages different intracellular mechanisms are responsible for the inflammatory response but also indicates that the interaction between astrocytes and macrophages plays an important role in the growing inflammatory response eventually leading to neurodegeneration.
